Skip to main content
NCBI home page
CMAJ : Canadian Medical Association Journal logoLink to CMAJ : Canadian Medical Association Journal
. 1992 Aug 15;147(4):420–428.

Guidelines for the assessment and management of chronic obstructive pulmonary disease. Canadian Thoracic Society Workshop Group.

PMCID: PMC1336240  PMID: 1498754

Abstract

Chronic obstructive pulmonary disease (COPD) is the fifth commonest cause of death in North America and is the only leading cause of death that is increasing in prevalence. Early detection and prevention through smoking cessation are essential to stem this epidemic. Once COPD is diagnosed there is a compelling rationale for vaccination against influenza and possibly pneumococcal pneumonia, although proof of efficacy is lacking. If airways obstruction is present, inhaled quaternary anticholinergic bronchodilators or inhaled beta 2 agonists or both may be of benefit, the former agents showing fewer side effects and often greater efficacy in elderly patients. Theophylline may enhance the effect or increase the duration of the bronchodilatation produced by an inhaled agent and may offer added nonbronchodilatory effects such as improved respiratory muscle endurance and ventilatory stimulation. If significant airflow obstruction persists, an objectively monitored trial of oral steroid therapy is required. Limitation of activity despite optimum medical therapy may be alleviated in selected patients by a supervised exercise rehabilitation program. If hypoxemia is present supplemental oxygen therapy will improve the patient's survival and quality of life. Additional therapies, from respiratory stimulants to lung transplantation, remain under investigation.

Full text

PDF
420

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Albert R. K., Martin T. R., Lewis S. W. Controlled clinical trial of methylprednisolone in patients with chronic bronchitis and acute respiratory insufficiency. Ann Intern Med. 1980 Jun;92(6):753–758. doi: 10.7326/0003-4819-92-6-753. [DOI] [PubMed] [Google Scholar]
  2. Anthonisen N. R. Long-term oxygen therapy. Ann Intern Med. 1983 Oct;99(4):519–527. doi: 10.7326/0003-4819-99-4-519. [DOI] [PubMed] [Google Scholar]
  3. Anthonisen N. R., Manfreda J., Warren C. P., Hershfield E. S., Harding G. K., Nelson N. A. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med. 1987 Feb;106(2):196–204. doi: 10.7326/0003-4819-106-2-196. [DOI] [PubMed] [Google Scholar]
  4. Anthonisen N. R., Wright E. C. Response to inhaled bronchodilators in COPD. Chest. 1987 May;91(5 Suppl):36S–39S. [PubMed] [Google Scholar]
  5. Aubier M., De Troyer A., Sampson M., Macklem P. T., Roussos C. Aminophylline improves diaphragmatic contractility. N Engl J Med. 1981 Jul 30;305(5):249–252. doi: 10.1056/NEJM198107303050503. [DOI] [PubMed] [Google Scholar]
  6. Aubier M., Murciano D., Fournier M., Milic-Emili J., Pariente R., Derenne J. P. Central respiratory drive in acute respiratory failure of patients with chronic obstructive pulmonary disease. Am Rev Respir Dis. 1980 Aug;122(2):191–199. doi: 10.1164/arrd.1980.122.2.191. [DOI] [PubMed] [Google Scholar]
  7. Barclay J., Whiting B., Addis G. J. The influence of theophylline on maximal response to salbutamol in severe chronic obstructive pulmonary disease. Eur J Clin Pharmacol. 1982;22(5):389–393. doi: 10.1007/BF00542540. [DOI] [PubMed] [Google Scholar]
  8. Berry R. B., Desa M. M., Branum J. P., Light R. W. Effect of theophylline on sleep and sleep-disordered breathing in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis. 1991 Feb;143(2):245–250. doi: 10.1164/ajrccm/143.2.245. [DOI] [PubMed] [Google Scholar]
  9. Blair G. P., Light R. W. Treatment of chronic obstructive pulmonary disease with corticosteroids. Comparison of daily vs alternate-day therapy. Chest. 1984 Oct;86(4):524–528. doi: 10.1378/chest.86.4.524. [DOI] [PubMed] [Google Scholar]
  10. Brochard L., Isabey D., Piquet J., Amaro P., Mancebo J., Messadi A. A., Brun-Buisson C., Rauss A., Lemaire F., Harf A. Reversal of acute exacerbations of chronic obstructive lung disease by inspiratory assistance with a face mask. N Engl J Med. 1990 Nov 29;323(22):1523–1530. doi: 10.1056/NEJM199011293232204. [DOI] [PubMed] [Google Scholar]
  11. CAMPBELL E. J., FRIEND J. Action of breathing exercises in pulmonary emphysema. Lancet. 1955 Feb 12;268(6859):325–329. doi: 10.1016/s0140-6736(55)90062-3. [DOI] [PubMed] [Google Scholar]
  12. Callahan C. M., Dittus R. S., Katz B. P. Oral corticosteroid therapy for patients with stable chronic obstructive pulmonary disease. A meta-analysis. Ann Intern Med. 1991 Feb 1;114(3):216–223. doi: 10.7326/0003-4819-114-3-216. [DOI] [PubMed] [Google Scholar]
  13. Calverley P. M., Leggett R. J., McElderry L., Flenley D. C. Cigarette smoking and secondary polycythemia in hypoxic cor pulmonale. Am Rev Respir Dis. 1982 May;125(5):507–510. doi: 10.1164/arrd.1982.125.5.507. [DOI] [PubMed] [Google Scholar]
  14. Carroll N., Branthwaite M. A. Control of nocturnal hypoventilation by nasal intermittent positive pressure ventilation. Thorax. 1988 May;43(5):349–353. doi: 10.1136/thx.43.5.349. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Chapman K. R., Smith D. L., Rebuck A. S., Leenen F. H. Hemodynamic effects of an inhaled beta-2 agonist. Clin Pharmacol Ther. 1984 Jun;35(6):762–767. doi: 10.1038/clpt.1984.108. [DOI] [PubMed] [Google Scholar]
  16. Chapman K. R., Smith D. L., Rebuck A. S., Leenen F. H. Hemodynamic effects of inhaled ipratropium bromide, alone and combined with an inhaled beta 2-agonist. Am Rev Respir Dis. 1985 Oct;132(4):845–847. doi: 10.1164/arrd.1985.132.4.845. [DOI] [PubMed] [Google Scholar]
  17. Clancy R., Cripps A., Murree-Allen K., Yeung S., Engel M. Oral immunisation with killed Haemophilus influenzae for protection against acute bronchitis in chronic obstructive lung disease. Lancet. 1985 Dec 21;2(8469-70):1395–1397. doi: 10.1016/s0140-6736(85)92559-0. [DOI] [PubMed] [Google Scholar]
  18. Cooper C. B., Waterhouse J., Howard P. Twelve year clinical study of patients with hypoxic cor pulmonale given long term domiciliary oxygen therapy. Thorax. 1987 Feb;42(2):105–110. doi: 10.1136/thx.42.2.105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Dolce J. J., Crisp C., Manzella B., Richards J. M., Hardin J. M., Bailey W. C. Medication adherence patterns in chronic obstructive pulmonary disease. Chest. 1991 Apr;99(4):837–841. doi: 10.1378/chest.99.4.837. [DOI] [PubMed] [Google Scholar]
  20. Eliasson O., Hoffman J., Trueb D., Frederick D., McCormick J. R. Corticosteroids in COPD. A clinical trial and reassessment of the literature. Chest. 1986 Apr;89(4):484–490. doi: 10.1378/chest.89.4.484. [DOI] [PubMed] [Google Scholar]
  21. Filuk R. B., Easton P. A., Anthonisen N. R. Responses to large doses of salbutamol and theophylline in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis. 1985 Oct;132(4):871–874. doi: 10.1164/arrd.1985.132.4.871. [DOI] [PubMed] [Google Scholar]
  22. Fisher E. B., Jr, Bishop D. B., Mayer J., Brown T., White-Cook T. The physicians's contribution to smoking cessation in the workplace. Chest. 1988 Feb;93(2 Suppl):56S–65S. doi: 10.1378/chest.93.2_supplement.56s. [DOI] [PubMed] [Google Scholar]
  23. Fletcher C., Peto R. The natural history of chronic airflow obstruction. Br Med J. 1977 Jun 25;1(6077):1645–1648. doi: 10.1136/bmj.1.6077.1645. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Fletcher E. C., Miller J., Divine G. W., Fletcher J. G., Miller T. Nocturnal oxyhemoglobin desaturation in COPD patients with arterial oxygen tensions above 60 mm Hg. Chest. 1987 Oct;92(4):604–608. doi: 10.1378/chest.92.4.604. [DOI] [PubMed] [Google Scholar]
  25. Gross N. J. Anticholinergic agents in COPD. Chest. 1987 May;91(5 Suppl):52S–57S. doi: 10.1378/chest.91.5_supplement.52s. [DOI] [PubMed] [Google Scholar]
  26. Gross N. J., Bankwala Z. Effects of an anticholinergic bronchodilator on arterial blood gases of hypoxemic patients with chronic obstructive pulmonary disease. Comparison with a beta-adrenergic agent. Am Rev Respir Dis. 1987 Nov;136(5):1091–1094. doi: 10.1164/ajrccm/136.5.1091. [DOI] [PubMed] [Google Scholar]
  27. Gross N. J., Skorodin M. S. Anticholinergic, antimuscarinic bronchodilators. Am Rev Respir Dis. 1984 May;129(5):856–870. doi: 10.1164/arrd.1984.129.5.856. [DOI] [PubMed] [Google Scholar]
  28. Guyatt G. H., Townsend M., Kazim F., Newhouse M. T. A controlled trial of ambroxol in chronic bronchitis. Chest. 1987 Oct;92(4):618–620. doi: 10.1378/chest.92.4.618. [DOI] [PubMed] [Google Scholar]
  29. Higgins M. W. Chronic airways disease in the United States. Trends and determinants. Chest. 1989 Sep;96(3 Suppl):328S–334S. [PubMed] [Google Scholar]
  30. Jones N. L. Conference on the scientific basis of respiratory therapy. Physical therapy--present state of the art. Am Rev Respir Dis. 1974 Dec;110(6 Pt 2):132–136. doi: 10.1164/arrd.1974.110.6P2.132. [DOI] [PubMed] [Google Scholar]
  31. Lam W. K., So S. Y., Yu D. Y. Response to oral corticosteroids in chronic airflow obstruction. Br J Dis Chest. 1983 Apr;77(2):189–198. doi: 10.1016/0007-0971(83)90027-x. [DOI] [PubMed] [Google Scholar]
  32. Lehmann D., Coakley K. J., Coakley C. A., Spooner V., Montgomery J. M., Michael A., Riley I. D., Smith T., Clancy R. L., Cripps A. W. Reduction in the incidence of acute bronchitis by an oral Haemophilus influenzae vaccine in patients with chronic bronchitis in the highlands of Papua New Guinea. Am Rev Respir Dis. 1991 Aug;144(2):324–330. doi: 10.1164/ajrccm/144.2.324. [DOI] [PubMed] [Google Scholar]
  33. Lenfant C. Arterial-alveolar difference in PCO2 during air and oxygen breathing. J Appl Physiol. 1966 Jul;21(4):1356–1362. doi: 10.1152/jappl.1966.21.4.1356. [DOI] [PubMed] [Google Scholar]
  34. MacNee W., Connaughton J. J., Rhind G. B., Hayhurst M. D., Douglas N. J., Muir A. L., Flenley D. C. A comparison of the effects of almitrine or oxygen breathing on pulmonary arterial pressure and right ventricular ejection fraction in hypoxic chronic bronchitis and emphysema. Am Rev Respir Dis. 1986 Sep;134(3):559–565. doi: 10.1164/arrd.1986.134.3.559. [DOI] [PubMed] [Google Scholar]
  35. Martin T. R., Lewis S. W., Albert R. K. The prognosis of patients with chronic obstructive pulmonary disease after hospitalization for acute respiratory failure. Chest. 1982 Sep;82(3):310–314. doi: 10.1378/chest.82.3.310. [DOI] [PubMed] [Google Scholar]
  36. Mendella L. A., Manfreda J., Warren C. P., Anthonisen N. R. Steroid response in stable chronic obstructive pulmonary disease. Ann Intern Med. 1982 Jan;96(1):17–21. doi: 10.7326/0003-4819-96-1-17. [DOI] [PubMed] [Google Scholar]
  37. Menzies R., Gibbons W., Goldberg P. Determinants of weaning and survival among patients with COPD who require mechanical ventilation for acute respiratory failure. Chest. 1989 Feb;95(2):398–405. doi: 10.1378/chest.95.2.398. [DOI] [PubMed] [Google Scholar]
  38. Mitchell D. M., Gildeh P., Dimond A. H., Collins J. V. Value of serial peak expiratory flow measurements in assessing treatment response in chronic airflow limitation. Thorax. 1986 Aug;41(8):606–610. doi: 10.1136/thx.41.8.606. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Murciano D., Aubier M., Lecocguic Y., Pariente R. Effects of theophylline on diaphragmatic strength and fatigue in patients with chronic obstructive pulmonary disease. N Engl J Med. 1984 Aug 9;311(6):349–353. doi: 10.1056/NEJM198408093110601. [DOI] [PubMed] [Google Scholar]
  40. Murciano D., Auclair M. H., Pariente R., Aubier M. A randomized, controlled trial of theophylline in patients with severe chronic obstructive pulmonary disease. N Engl J Med. 1989 Jun 8;320(23):1521–1525. doi: 10.1056/NEJM198906083202304. [DOI] [PubMed] [Google Scholar]
  41. Nattie E. E., Bartlett D., Jr, Johnson K. Pulmonary hypertension and right ventricular hypertrophy caused by intermittent hypoxia and hypercapnia in the rat. Am Rev Respir Dis. 1978 Oct;118(4):653–658. doi: 10.1164/arrd.1978.118.4.653. [DOI] [PubMed] [Google Scholar]
  42. Newhouse M. T., Dolovich M. Aerosol therapy of reversible airflow obstruction. Concepts and clinical applications. Chest. 1987 May;91(5 Suppl):58S–64S. [PubMed] [Google Scholar]
  43. Ornish S. A., Zisook S., McAdams L. A. Effects of transdermal clonidine treatment on withdrawal symptoms associated with smoking cessation. A randomized, controlled trial. Arch Intern Med. 1988 Sep;148(9):2027–2031. [PubMed] [Google Scholar]
  44. Pakes G. E., Brogden R. N., Heel R. C., Speight T. M., Avery G. S. Ipratropium bromide: a review of its pharmacological properties and therapeutic efficacy in asthma and chronic bronchitis. Drugs. 1980 Oct;20(4):237–266. doi: 10.2165/00003495-198020040-00001. [DOI] [PubMed] [Google Scholar]
  45. Patterson G. A., Maurer J. R., Williams T. J., Cardoso P. G., Scavuzzo M., Todd T. R. Comparison of outcomes of double and single lung transplantation for obstructive lung disease. The Toronto Lung Transplant Group. J Thorac Cardiovasc Surg. 1991 Apr;101(4):623–632. [PubMed] [Google Scholar]
  46. Pearlman R. A. Variability in physician estimates of survival for acute respiratory failure in chronic obstructive pulmonary disease. Chest. 1987 Apr;91(4):515–521. doi: 10.1378/chest.91.4.515. [DOI] [PubMed] [Google Scholar]
  47. Petty T. L. The National Mucolytic Study. Results of a randomized, double-blind, placebo-controlled study of iodinated glycerol in chronic obstructive bronchitis. Chest. 1990 Jan;97(1):75–83. doi: 10.1378/chest.97.1.75. [DOI] [PubMed] [Google Scholar]
  48. Rebuck A. S., Chapman K. R., Abboud R., Pare P. D., Kreisman H., Wolkove N., Vickerson F. Nebulized anticholinergic and sympathomimetic treatment of asthma and chronic obstructive airways disease in the emergency room. Am J Med. 1987 Jan;82(1):59–64. doi: 10.1016/0002-9343(87)90378-0. [DOI] [PubMed] [Google Scholar]
  49. Rice K. L., Leatherman J. W., Duane P. G., Snyder L. S., Harmon K. R., Abel J., Niewoehner D. E. Aminophylline for acute exacerbations of chronic obstructive pulmonary disease. A controlled trial. Ann Intern Med. 1987 Sep;107(3):305–309. doi: 10.7326/0003-4819-107-2-305. [DOI] [PubMed] [Google Scholar]
  50. Rogers R. M., Owens G. R., Pennock B. E. The pendulum swings again. Toward a rational use of theophylline. Chest. 1985 Mar;87(3):280–282. doi: 10.1378/chest.87.3.280. [DOI] [PubMed] [Google Scholar]
  51. Sassoon C. S., Hassell K. T., Mahutte C. K. Hyperoxic-induced hypercapnia in stable chronic obstructive pulmonary disease. Am Rev Respir Dis. 1987 Apr;135(4):907–911. doi: 10.1164/arrd.1987.135.4.907. [DOI] [PubMed] [Google Scholar]
  52. Sears M. R., Taylor D. R., Print C. G., Lake D. C., Li Q. Q., Flannery E. M., Yates D. M., Lucas M. K., Herbison G. P. Regular inhaled beta-agonist treatment in bronchial asthma. Lancet. 1990 Dec 8;336(8728):1391–1396. doi: 10.1016/0140-6736(90)93098-a. [DOI] [PubMed] [Google Scholar]
  53. Shim C. S., Williams M. H., Jr Aerosol beclomethasone in patients with steroid-responsive chronic obstructive pulmonary disease. Am J Med. 1985 Apr;78(4):655–658. doi: 10.1016/0002-9343(85)90409-7. [DOI] [PubMed] [Google Scholar]
  54. Sonne L. J., Davis J. A. Increased exercise performance in patients with severe COPD following inspiratory resistive training. Chest. 1982 Apr;81(4):436–439. doi: 10.1378/chest.81.4.436. [DOI] [PubMed] [Google Scholar]
  55. Syed A., Hoeppner V. H., Cockcroft D. W. Prediction of nonresponse to corticosteroids in stable chronic airflow limitation. Clin Invest Med. 1991 Feb;14(1):28–34. [PubMed] [Google Scholar]
  56. Tønnesen P., Fryd V., Hansen M., Helsted J., Gunnersen A. B., Forchammer H., Stockner M. Effect of nicotine chewing gum in combination with group counseling on the cessation of smoking. N Engl J Med. 1988 Jan 7;318(1):15–18. doi: 10.1056/NEJM198801073180104. [DOI] [PubMed] [Google Scholar]
  57. Ullah M. I., Newman G. B., Saunders K. B. Influence of age on response to ipratropium and salbutamol in asthma. Thorax. 1981 Jul;36(7):523–529. doi: 10.1136/thx.36.7.523. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Wanner A. Effect of ipratropium bromide on airway mucociliary function. Am J Med. 1986 Nov 14;81(5A):23–27. doi: 10.1016/0002-9343(86)90458-4. [DOI] [PubMed] [Google Scholar]
  59. Wanner A. Effects of methylxanthines on airway mucociliary function. Am J Med. 1985 Dec 20;79(6A):16–21. doi: 10.1016/0002-9343(85)90082-8. [DOI] [PubMed] [Google Scholar]
  60. Weir D. C., Gove R. I., Robertson A. S., Burge P. S. Corticosteroid trials in non-asthmatic chronic airflow obstruction: a comparison of oral prednisolone and inhaled beclomethasone dipropionate. Thorax. 1990 Feb;45(2):112–117. doi: 10.1136/thx.45.2.112. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Wewers M. D., Casolaro M. A., Sellers S. E., Swayze S. C., McPhaul K. M., Wittes J. T., Crystal R. G. Replacement therapy for alpha 1-antitrypsin deficiency associated with emphysema. N Engl J Med. 1987 Apr 23;316(17):1055–1062. doi: 10.1056/NEJM198704233161704. [DOI] [PubMed] [Google Scholar]
  62. Williams J. H., Jr Continuing controversy: pneumococcal vaccine and COPD. Chest. 1987 Aug;92(2):193–194. doi: 10.1378/chest.92.2.193. [DOI] [PubMed] [Google Scholar]
  63. Wright J. L., Barry W., Paré P. D., Hogg J. C. Ranking the severity of emphysema on whole lung slices. Concordance of upper lobe, lower lobe, and entire lung ranks. Am Rev Respir Dis. 1986 May;133(5):930–931. [PubMed] [Google Scholar]
  64. van Schayck C. P., Graafsma S. J., Visch M. B., Dompeling E., van Weel C., van Herwaarden C. L. Increased bronchial hyperresponsiveness after inhaling salbutamol during 1 year is not caused by subsensitization to salbutamol. J Allergy Clin Immunol. 1990 Nov;86(5):793–800. doi: 10.1016/s0091-6749(05)80185-x. [DOI] [PubMed] [Google Scholar]

Articles from CMAJ: Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES